Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06248567
Status:
RECRUITING
Last Update Posted:
2024-02-08
First Post:
2024-01-31
Brief Title:
Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease
Sponsor:
Guangdong Raynovent Biotech Co Ltd
Organization:
Guangdong Raynovent Biotech Co Ltd
Study Overview
Official Title:
A Phase I Single Dose Non-Randomised Open-Label Parallel Group Study to Investigate the Effect of Severe Kidney Impairment on the Pharmacokinetics Safety and Tolerability of ZSP1273
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the effect of severe kidney impairment on the pharmacokinetics PK safety and tolerability of ZSP1273
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None